Diseases, Conditions, Syndromes

Neuropilin-1 drives SARS-CoV-2 infectivity, finds breakthrough study

In a major breakthrough an international team of scientists, led by the University of Bristol, has potentially identified what makes SARS-CoV-2 highly infectious and able to spread rapidly in human cells. The findings, published ...

Medical research

Study identifies antibodies that block alphaviruses

Researchers at Vanderbilt University Medical Center have identified antibodies that, in animals, block infection by alphaviruses, which can cause chronic and debilitating joint pain and arthritis and are an increasing global ...

Diseases, Conditions, Syndromes

Which antibodies are most effective against coronavirus?

Researchers Indu Khatri, Frank Staal and Jacques van Dongen from Leiden University Medical Center (LUMC) have published a perspective article in Frontiers in Immunology about coronavirus and its characteristic spike protein. ...

Medical research

A promising therapeutic modality against the coronavirus

Since the emergence of the novel coronavirus in late 2019, multiple approaches for treating COVID-19 have been considered, from the use of repurposed medicines such as the antimalarial drug, hydroxychloroquine, to the Ebola ...

Oncology & Cancer

New immunotherapy to beat cancer

Sophie Lucas (University of Louvain de Duve Institute) and her team have succeeded in neutralizing a molecule that blocks the immune system against cancer. The UCLouvain scientists discovered that this new immunotherapy increases ...

page 1 from 22